Article
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
JAMA - 13 Dec 2016
Iversen Ole-Erik, Miranda Maria Jose, Ulied Angels, Soerdal Terje, Lazarus Erica, Chokephaibulkit Kulkanya, Block Stan L, Skrivanek Ales, Nur Azurah Abdul Ghani, Fong Siew Moy, Dvorak Vladimir, Kim Kyung-Hyo, Cestero Ramon M, Berkovitch Matitiahu, Ceyhan Mehmet, Ellison Misoo C, Ritter Michael A, Yuan Shuai S, DiNubile Mark J, Saah Alfred J, Luxembourg Alain
Abstract excerpt
Importance: Human papillomavirus (HPV) infections cause anogenital cancers and warts. The 9-valent HPV vaccine provides protection against 7 high-risk types of HPV responsible for 90% of cervical cancers and 2 other HPV types accounting for 90% of genital warts. Objective: To determine whether HPV type-specific antibody responses would be noninferior among girls and boys aged 9 to 14 years after receiving 2 doses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.